Get started
Author

Robert K. M. Choy

Observed names: Choy, Robert K M, Choy, Robert K. M., Choy, Robert K.M., Choy, Robert KM, Robert Choy, Robert K M Choy, Robert K.M Choy, Robert K.M. Choy, Robert KM Choy
Observed institutions: Program for Appropriate Technology in Health, University of Liverpool, Exelixis (United States), University of Washington, Fred Hutch Cancer Center, Program for Appropriate Technology in Health, Saint Louis University
ORCID: 0000-0002-8441-4029
Observed ORCID: 0000-0002-8441-4029
OpenAlex ID: A5065831756
Therapeutic antibody targeting of individual Notch receptors
2010 · Yan Wu, Carol Cain-Hom, et al. · Nature · 720
Fluoxetine-Resistant Mutants in C. elegans Define a Novel Family of Transmembrane Proteins
1999 · Robert K.M. Choy, James H. Thomas · Molecular Cell · 116
PDF
Functional Analysis ofDrosophilaand Mammalian Cut Proteins in Flies
1996 · Cathy Ludlow, Robert Choy, et al. · Developmental Biology · 54
PDF
Optimization of Methionyl tRNA-Synthetase Inhibitors for Treatment of Cryptosporidium Infection
2019 · Frederick S. Buckner, Ranae M. Ranade, et al. · Antimicrobial Agents and Chemotherapy · 53
PDF
Bumped Kinase Inhibitors as therapy for apicomplexan parasitic diseases: lessons learned
2020 · Ryan Choi, Matthew A. Hulverson, et al. · International Journal for Parasitology · 52
PDF
Fluoxetine-Resistance Genes inCaenorhabditis elegansFunction in the Intestine and May Act in Drug Transport
2005 · Robert K M Choy, John M Kemner, et al. · Genetics · 52
Addressing Cryptosporidium Infection among Young Children in Low-Income Settings: The Crucial Role of New and Existing Drugs for Reducing Morbidity and Mortality
2016 · David A. Shoultz, Eugenio L. de Hostos, et al. · PLoS neglected tropical diseases · 46
PDF
Controlled Human Infection Models To Accelerate Vaccine Development
2022 · Robert K. M. Choy, A. Louis Bourgeois, et al. · Clinical Microbiology Reviews · 44
Developing Novel Antisecretory Drugs to Treat Infectious Diarrhea
2011 · Eugenio L de Hostos, Robert K M Choy, et al. · Future Medicinal Chemistry · 43
Vaccines for Protecting Infants from Bacterial Causes of Diarrheal Disease
2021 · Richard Walker, Robert W. Kaminski, et al. · Microorganisms · 42
PDF
Emerging treatment options for cryptosporidiosis
2021 · Melissa S. Love, Robert K.M. Choy · Current Opinion in Infectious Diseases · 41
Chemical Genetics Reveals an RGS/G-Protein Role in the Action of a Compound
2006 · Kevin Fitzgerald, Svetlana Tertyshnikova, et al. · PLoS Genetics · 37
PDF
Spontaneous Selection of Cryptosporidium Drug Resistance in a Calf Model of Infection
2021 · Muhammad M. Hasan, Erin E. Stebbins, et al. · Antimicrobial Agents and Chemotherapy · 33
PDF
Validation of the Micronutrient and Environmental Enteric Dysfunction Assessment Tool and evaluation of biomarker risk factors for growth faltering and vaccine failure in young Malian children
2020 · Michael B. Arndt, Jason L. Cantera, et al. · PLoS neglected tropical diseases · 32
PDF
A Bilayer Microarray Patch (MAP) for HIV Pre-Exposure Prophylaxis: The Role of MAP Designs and Formulation Composition in Enhancing Long-Acting Drug Delivery
2024 · Lalitkumar K. Vora, Ismaiel A. Tekko, et al. · Pharmaceutics · 20
PDF
A Phase 2a randomized, single-center, double-blind, placebo-controlled study to evaluate the safety and preliminary efficacy of oral iOWH032 against cholera diarrhea in a controlled human infection model
2021 · Rahsan Erdem, Gwen Ambler, et al. · PLoS neglected tropical diseases · 17
PDF
Biomarkers of environmental enteric dysfunction and adverse birth outcomes: An observational study among pregnant women living with HIV in Tanzania
2022 · Miles A. Kirby, Jacqueline M. Lauer, et al. · EBioMedicine · 16
Protocol for the challenge non-typhoidalSalmonella(CHANTS) study: a first-in-human, in-patient, double-blind, randomised, safety and dose-escalation controlled human infection model in the UK
2024 · Christopher Smith, Emma Smith, et al. · BMJ Open · 15
PDF
Cryptosporidiosis should be designated as a tropical disease by the US Food and Drug Administration
2020 · Robert K. M. Choy, Christopher D. Huston · PLoS neglected tropical diseases · 14
PDF
Fourth Controlled Human Infection Model (CHIM) meeting, CHIM regulatory issues, May 24, 2023
2024 · Marco Cavaleri, David Kaslow, et al. · Biologicals · 13
Structure-guided discovery of selective methionyl-tRNA synthetase inhibitors with potent activity against Trypanosoma brucei
2020 · Zhongsheng Zhang, Ximena Barros-Álvarez, et al. · RSC Medicinal Chemistry · 13
Pharmacologic Comparison of Clinical Neutral Endopeptidase Inhibitors in a Rat Model of Acute Secretory Diarrhea
2016 · David W. Griggs, Michael J. Prinsen, et al. · Journal of Pharmacology and Experimental Therapeutics · 12
PDF
The Challenge Non-Typhoidal Salmonella (CHANTS) Consortium: Development of a non-typhoidal Salmonella controlled human infection model: Report from a consultation group workshop, 05 July 2022, London, UK
2023 · Christopher Smith, Emma Smith, et al. · Wellcome Open Research · 9
Assessing environmental enteric dysfunction via multiplex assay and its relation to growth and development among HIV-exposed uninfected Tanzanian infants
2023 · Jacqueline M. Lauer, Miles A. Kirby, et al. · PLoS neglected tropical diseases · 8
PDF
Development of Norelgestromin Dissolving Bilayer Microarray Patches for Sustained Release of Hormonal Contraceptive
2024 · Lalitkumar K. Vora, Ismaiel A. Tekko, et al. · Pharmaceutics · 7
Works count: 47
Citation count: 1,532
H-index: 16
I10-index: 22
Year
Topic
Type